American Shared Hospital Service (AMS)

This article provides recent news for American Shared Hospital Services (AMS) stock, highlighting its current trading price and market performance. The most recent development is the company's Q2 2026 earnings call, where it reported a 19.2% increase in revenue. Investors can follow AMS news, earnings, and analyst ratings on TradingKey.

This article provides a detailed financial overview of American Shared Hospital Services (AMS), including its live stock price, key figures, technical analysis, and earnings call transcripts. It highlights the company's Q2 2026 earnings with a 19.2% revenue increase and outlines its business as a provider of stereotactic radiosurgery and advanced radiation therapy equipment. The report also includes ownership details and an analyst rating, though specific current ratings are not provided.

American Shared Hospital Services (AMS) reported strong financial results for the second quarter and first half of 2026, with second-quarter revenue increasing 19% to $8.4 million, driven by growth in direct patient services and proton beam radiation therapy. Operating cash flow reached $4.4 million in the first half of 2026, and the company is focused on strategic growth initiatives, including expanding its advanced radiation therapy technologies and strengthening its financial position. Despite a net loss due to legal costs and increased credit loss allowance, the company's core business fundamentals remain strong, supported by increased procedure volumes and improved reimbursement.

American Shared Hospital Services (AMS) reported a wider-than-expected loss of $0.07 per share for Q2 2026, against an expected loss of $0.02. Despite the net loss of $514,000, the company achieved strong revenue growth, with total revenue climbing 19.0% to $8.4 million, driven primarily by a 40.0% increase in Direct Patient Services revenue. Analysts maintain a positive outlook on the stock, with the company benefiting from increased demand for its specialized radiation therapy equipment.

American Shared Hospital Services (AMS) reported a Q2 2026 revenue of $8.4 million, surpassing analyst expectations, driven by growth in direct patient services and proton beam revenue. Despite the revenue beat, the company posted a wider-than-expected loss per share of $0.07 due to non-operating charges. Management highlighted strategic transformation, strong cash generation, and progress in refinancing debt, while addressing analyst concerns about a significant credit loss allowance.